A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.
Iwahori K, Nii T, Yamaguchi N, Kawasaki T, Okamura S, Hashimoto K, Matsuki T, Tsujino K, Miki K, Osa A, Goya S, Abe K, Mori M, Takeda Y, Yamada T, Kida H, Kumanogoh A.
Iwahori K, et al. Among authors: mori m.
Sci Rep. 2023 Aug 23;13(1):13809. doi: 10.1038/s41598-023-41051-2.
Sci Rep. 2023.
PMID: 37612352
Free PMC article.
Clinical Trial.